Knowledge

Here you learn about the businesses and environment you’re working in. Knowing this, will help you to make better decisions and understand the bigger picture.

Behind the scenes of The Effective Statistician

Podcasts have become a popular form of media for sharing information, telling stories, and building an audience. But have you ever wondered what goes on behind the scenes of creating a successful podcast? Today, I have the pleasure of sitting down with Reine Escalona and Kacey Tunac, the podcast production and management team called VVS, …

Behind the scenes of The Effective Statistician Read More »

Three Things to Learn About Yourself That Will Make a Huge Difference

Personal growth is an integral part of every individual’s life. It is a continuous process of self-improvement, learning, and self-discovery. Also, as a statistician you should always be on a quest for personal and professional development. The journey towards growth is unique, and understanding yourself is a critical step towards achieving your potential. In this …

Three Things to Learn About Yourself That Will Make a Huge Difference Read More »

PSI Book Club – dare to lead review

In today’s highly competitive work environment, developing leadership skills such as vulnerability and empathy will mean the difference between success and failure. In this podcast episode, Marius and I discuss Brené Brown’s “Dare to Lead”, a book that dives into the importance of vulnerability-based leadership. This episode will explore some of the key takeaways from the book …

PSI Book Club – dare to lead review Read More »

Killer statistician

In the field of statistics, we need specific skills necessary for being successfull. Debarshi Dey, currently the head of the Statistics and Programming and Data Management department at Morphosys, has spent the past 13 years in the pharmaceutical industry. With a PhD in statistics from UC Riverside, Debarshi believes that to be a “killer statistician,” …

Killer statistician Read More »

The recent Alzheimer story – an absolute low for the industry and especially for statisticians

End of last year, a congressional report about the approval of an Alzheimer drug by the FDA was published. It critiques both the FDA and the sponsor company Biogen. Reuters and many other major news organisations reported about it. Today, I interviewed Anja Schiel about this topic. We talked about the background of Alzheimer and …

The recent Alzheimer story – an absolute low for the industry and especially for statisticians Read More »